Article
Pathways with an impact on effects of metronomic chemotherapy with a fluoropyrimidine prodrug, S-1
2025-04-21
Abstract excerpt
<h4>Background: </h4> and Purpose Adjuvant chemotherapy with 5-fluorouracil (5-FU) prodrugs is now the standard of care for stage I–III oral squamous cell carcinoma (OSCC); however, it remains to be clarified for which patient neoadjuvant chemotherapy with 5-FU prodrugs may be an option. Experimental Approach In the Ryukyu cohort [neoadjuvant chemotherapy with 5-FU prodrugs (UFT or S-1) + bleomycin, neoadjuvant ch...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7e206100-a16f-5151-a239-ab9f5a13f919
- DOI
- 10.22541/au.174521795.53239906/v1
